Lesson 1Hepatitis A and B: risk rationale, schedules and accelerated options, special considerationsThis section examines hepatitis A and B risks for travelers, including food, water, and blood-borne exposures. It reviews standard and accelerated schedules, combined vaccines, post-exposure options, and special considerations for chronic liver disease.
Hepatitis A risk by destination and behaviorHepatitis B risk from sex, work, and proceduresStandard and accelerated vaccine schedulesCombined A/B vaccines and catch-up planningChronic liver disease and immunocompromised careLesson 2Vaccine safety, contraindications, pregnancy considerations, and managing vaccine interactionsThis section reviews core vaccine safety principles, absolute and relative contraindications, and precautions in pregnancy and immunosuppression, with emphasis on managing coadministration, drug interactions, and adverse event counseling for travelers.
Screening for contraindications and precautionsLive versus inactivated vaccines in travelersVaccination in pregnancy and breastfeedingManaging immunosuppressed and chronically ill travelersCoadministration, spacing, and drug interactionsLesson 3COVID-19 vaccination and boosters: current recommendations for travelers and timing before departureThis section summarizes current COVID-19 vaccine and booster guidance for travelers, including product selection, variant-updated formulations, and timing before departure. It addresses high-risk groups, coadministration, and documentation for entry rules.
Assessing baseline COVID-19 vaccination statusCurrent booster indications and product choiceTiming doses before departure and eventsHigh-risk travelers and additional precautionsCoadministration and proof for border controlsLesson 4Japanese encephalitis: risk assessment for rural India and Amazon-edge exposures, vaccine indications and timingThis section addresses Japanese encephalitis risk for rural India and Amazon-edge travel, including vector ecology, seasonality, and exposure patterns. It covers vaccine indications, schedules, timing before departure, and counseling on residual risk.
Geographic and seasonal risk in India and AmazonIdentifying high-risk itineraries and activitiesJE vaccine products, schedules, and age limitsTiming doses before departure and boostersResidual risk and mosquito avoidance counselingLesson 5Meningococcal vaccines: epidemiology in West Africa and indications for short-term travelersThis section reviews meningococcal epidemiology in West Africa, including the meningitis belt and seasonal patterns. It explains vaccine types, indications for short-term travelers, timing before departure, and documentation for Hajj and Umrah.
Meningitis belt geography and seasonalitySerogroups and available vaccine formulationsIndications for short-term and high-risk travelersTiming, boosters, and coadministrationHajj, Umrah, and country entry requirementsLesson 6Rabies pre-exposure vaccination: risk assessment for jungle and rural work, schedule, and post-exposure implicationsThis section explains rabies risk for jungle and rural work, including animal reservoirs and exposure patterns. It details pre-exposure vaccine schedules, accelerated options, and how prior vaccination changes post-exposure prophylaxis needs and logistics.
Rabies epidemiology and key animal reservoirsRisk assessment for jungle and rural travelersStandard and accelerated pre-exposure schedulesSerologic testing and booster considerationsPost-exposure management in previously vaccinatedLesson 7Typhoid fever: oral vs injectable vaccines, indications for Nigeria and India, timing and efficacyThis section compares oral and injectable typhoid vaccines, including immunogenicity, duration of protection, and side effects. It emphasizes indications, timing, and efficacy for travelers to Nigeria and India, and integration with other pre-travel vaccines.
Typhoid risk in Nigeria and India by itineraryOral Ty21a schedule, efficacy, and limitationsInjectable Vi polysaccharide schedule and efficacyChoosing oral vs injectable for specific travelersBooster timing and coordination with other vaccinesLesson 8Yellow fever: indication, evidence for Nigeria and Brazil (Amazon), timing, contraindications, and international certificate rulesThis section covers yellow fever epidemiology, indications for vaccination, and evidence for risk in Nigeria and Brazil, including Amazon regions. It details timing, contraindications, adverse events, and international certificate regulations for travelers.
Yellow fever transmission in Nigeria and BrazilAssessing individual risk and vaccine indicationContraindications and precautions to vaccinationTiming, boosters, and managing side effectsInternational certificate rules and exemptionsLesson 9Polio: adult booster considerations for travel to endemic or outbreak-risk countriesThis section reviews global polio epidemiology and identifies travelers needing adult IPV boosters for endemic or outbreak-risk destinations. It covers timing, documentation, and coordination with other vaccines and International Health Regulations.
Current polio-endemic and outbreak countriesDetermining need for adult IPV boosterBooster timing before departure and durationDocumentation and IHR-related requirementsIntegrating IPV with other travel vaccinesLesson 10Routine immunizations review and catch-up relevant for adult travelers (Td/Tdap, MMR, varicella, IPV, HPV, annual influenza)This section revisits adult routine immunizations relevant to travelers, including Td/Tdap, MMR, varicella, IPV, HPV, and influenza. Learners will identify gaps, apply catch-up schedules, and prioritize updates before international trips.
Assessing adult vaccine history and documentationTd/Tdap boosters and wound management abroadMMR and varicella immunity for international travelIPV, HPV, and age-specific considerationsAnnual influenza vaccination and travel timing
